Cefuroxime Axetil
Product Images NDC 53002-2750

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefuroxime Axetil (NDC 53002-2750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefuroxime-structure (Cefuroxime Structure)

Cefuroxime-structure (Cefuroxime Structure)
Chemical structure of cefuroxime axetil, an active ingredient in the antibiotic product from RPK Pharmaceuticals, Inc. The diagram shows the molecular arrangement of atoms and bonds specific to cefuroxime axetil's compound.*
FDA Label Image

Label Image (Lbl530022750)

Label Image (Lbl530022750)
Packaging label for Cefuroxime Axetil 250 mg tablets by RPK Pharmaceuticals, Inc. The label shows the dosage form as tablets with a quantity of 20 tablets per bottle. Directions include taking one tablet twice a day for 10 days or as directed. The label includes Rx only designation and space for clinic name and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.